| Fund ID | 805-1073047392 |
| Fund type | Private Equity Fund |
| 3(c)(1) exclusion | No |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 92% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 0% |
| Fund | Type | Gross assets |
|---|---|---|
| Rpi International Partners 2019, LP | Private Equity | $22M |
Rpi US Partners 2019, LP reports $1.7 billion in gross assets, among the top 4% of private funds by size.
Rpi US Partners 2019, LP is managed by Royalty Pharma Sub-Manager, LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.